To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have CD3-positive HTLV-1-associated leukemia or lymphoma.
- This study is open to patients who have had no prior therapy as well as those who had previous treatment.
- Patients must be age 18 or older.
For more information about this study and to inquire about eligibility, please contact Dr. Ariela Noy at 212-639-7423.